The colon cancer group showed a marked increase in serum levels of CA19.9, CEA, AFP, TNF-α, IL-1β, and colon DNA-fragmentation matched with a decrease of CD4+ compared with the control group. The gene discussed is IL1B; the disease is malignant colon neoplasm.